Designed mosaic nanoparticles enhance cross-reactive immune responses in mice
Cell · 2025-02 · 188 (4) · 1036-1050.e11
DOI: 10.1016/j.cell.2024.12.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2025-02. Verfasst von Eric Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Hauptthemen laut MEDLINE: Nanoparticles, SARS-CoV-2, COVID-19, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill & Melinda Gates Foundation, NIAID NIH HHS, Bill and Melinda Gates Foundation.
Abstract (Originalsprache)
Nanoparticle vaccines displaying combinations of SARS-like betacoronavirus (sarbecovirus) receptor-binding domains (RBDs) could protect against SARS-CoV-2 variants and spillover of zoonotic sarbecoviruses into humans. Using a computational approach, we designed variants of SARS-CoV-2 RBDs and selected 7 natural sarbecovirus RBDs, each predicted to fold properly and abrogate antibody responses to variable epitopes. RBDs were attached to 60-mer nanoparticles to make immunogens displaying two (mosaic-2COMs), five (mosaic-5COM), or seven (mosaic-7COM) different RBDs for comparisons with mosaic-8b, which elicited cross-reactive antibodies and protected animals from sarbecovirus challenges. Naive and COVID-19 pre-vaccinated mice immunized with mosaic-7COM elicited antibodies targeting conserved RBD epitopes, and their sera exhibited higher binding and neutralization titers against sarbecoviruses than mosaic-8b. Mosaic-2COMs and mosaic-5COM elicited higher antibody potencies against some SARS-CoV-2 variants than mosaic-7COM. However, mosaic-7COM elicited more potent responses against zoonotic sarbecoviruses and highly mutated Omicrons, supporting its use to protect against SARS-CoV-2 variants and zoonotic sarbecoviruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
- Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
- Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA. Electronic address: bjorkman@caltech.edu.
- Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Depart…
Förderung
- Bill & Melinda Gates Foundation
- NIAID NIH HHS
- Bill and Melinda Gates Foundation
- National Science Foundation Graduate Research Fellowship Program
- University of Washington
- California Institute of Technology Merkin Institute for Translational Research
- National Institutes of Health
- University of Utah
Zitieren
APA
Wang, E., Cohen, A. A., Caldera, L. F., Keeffe, J. R., Rorick, A. V., Adia, Y. M., Gnanapragasam, P. N. P., Bjorkman, P. J., & Chakraborty, A. K. (2025). Designed mosaic nanoparticles enhance cross-reactive immune responses in mice. Cell, 188(4), 1036-1050.e11. https://doi.org/10.1016/j.cell.2024.12.015
Vancouver
Wang E, Cohen AA, Caldera LF, Keeffe JR, Rorick AV, Adia YM, et al. Designed mosaic nanoparticles enhance cross-reactive immune responses in mice. Cell. 2025;188(4):1036-1050.e11. doi:10.1016/j.cell.2024.12.015
BibTeX
@article{Wang2025,
author = {Wang, Eric and Cohen, Alexander A and Caldera, Luis F and Keeffe, Jennifer R and Rorick, Annie V and Adia, Yusuf M and Gnanapragasam, Priyanthi N P and Bjorkman, Pamela J and Chakraborty, Arup K},
title = {Designed mosaic nanoparticles enhance cross-reactive immune responses in mice},
journal = {Cell},
year = {2025},
volume = {188},
number = {4},
pages = {1036--1050.e11},
doi = {10.1016/j.cell.2024.12.015}
}
EUVIMED